mva.hiva
Vaccineexperimental
Clinical trial activity
3 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2003 (NCT01371175)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva.hiva
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00981695 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2009 | European and Developing Countries Clinical Trials Partnership (EDCTP), Karolinska Institute, Medical Research Council, University of Nairobi, University of Washington |
| NCT00982579 | Phase 1 | Nov 1, 2009 | European and Developing Countries Clinical Trials Partnership (EDCTP), Karolinska Institute, Medical Research Council, Medical Research Council, The Gambia |
| NCT01371175 | Phase 2 | Apr 1, 2003 | International AIDS Vaccine Initiative, Kenya AIDS Vaccine Initiative, Medical Research Council, University of London, University of Nairobi |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical Research Council | Government | 3 | 2 | 2 | 2003 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 2 | 0 | 2 | 2009 |
| Karolinska Institute | Academic/Hospital | 2 | 0 | 2 | 2009 |
| University of Nairobi | Academic/Hospital | 2 | 0 | 1 | 2003 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Kenya AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Medical Research Council, The Gambia | Government | 1 | 0 | 1 | 2009 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2009 |
9 organizations
Page 1 / 1